Medications & Supplements/Prescription Drugs

Atenolol 25mg Tablets Recalled for Label Mix-up with Clopidogrel 75mg

Agency Publication Date: October 21, 2022

Summary

Golden State Medical Supply Inc. is recalling 2,584 bottles of Atenolol (25 mg) tablets because some bottles were mistakenly filled with Clopidogrel (75 mg) tablets. Atenolol is used to treat high blood pressure and chest pain, while Clopidogrel is a blood thinner. The recalled products are 1,000-count bottles that were distributed nationwide. Patients may notice that instead of the expected white tablets, the bottle contains pink tablets.

Risk

Patients who unknowingly take Clopidogrel instead of their prescribed Atenolol will miss their necessary blood pressure medication and receive a blood thinner they were not intended to have. This can cause uncontrolled blood pressure or heart conditions and significantly increases the risk of dangerous, unintended bleeding.

What You Should Do

This recall affects 1,000-count bottles of Atenolol Tablets, USP (25 mg) marketed by GSMS, Incorporated with NDC 60429-027-10, lot number GS046745, and expiration date 12/2023.
Identify the medication inside your bottle: the intended Atenolol tablets are white and round with 'M' on one side and 'A2' on the other, while the mislabeled Clopidogrel tablets are pink and round with 'APO' on one side and 'CL 75' on the other.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact GSMS, Incorporated for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Atenolol Tablets, USP (25 mg), 1000-count bottleby GSMS, Incorporated

Variants: 25 mg, 1,000 tablets, Tablet, Rx Only

Lot Numbers:

GS046745 (Exp 12/2023)

NDC:

60429-027-10

GTIN:

00351407032102

Recalled bottles contain Clopidogrel 75mg tablets instead of the labeled Atenolol 25mg tablets.

Product Images

Product labeling, Clopidogrel Tablets, USP 75mg 1,000 count bottles, NDC 51407-032-10

Product image, Clopidogrel Tablets

Product labeling, Atenolol Tablets, USP 25mg 1,000 count bottles NDC 60429-027-10

Product image, Atenolol Tablets

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 90909

Status: Resolved

Manufacturer: Golden State Medical Supply Inc.

Sold By: pharmacies; GSMS, Incorporated

Manufactured In: United States

Units Affected: 2,584 Bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

Risk

What You Should Do

This recall affects 1,000-count bottles of Atenolol Tablets, USP (25 mg) marketed by GSMS, Incorporated with NDC 60429-027-10, lot number GS046745, and expiration date 12/2023.

Identify the medication inside your bottle: the intended Atenolol tablets are white and round with 'M' on one side and 'A2' on the other, while the mislabeled Clopidogrel tablets are pink and round with 'APO' on one side and 'CL 75' on the other.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact GSMS, Incorporated for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.